CIK 0001781983 · Non-accelerated filer<br>Smaller reporting company
Aprea Therapeutics, Inc.
Sign in to watch- Ticker
- APRE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 215-948-4119
- Business address
- 3805 OLD EASTON ROAD, DOYLESTOWN, PA, 18902
- 4 Other disposition 10% owner disposed of 3,418,692 shares (other)
- 4 Other disposition 10% owner disposed of 120,148 shares (other)
- 4 Open-market sale 10% owner sold 210,548 shares at $31.25 ($6,579,625)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy 10% owner bought 333,333 shares at $15.00 ($4,999,995)
- 4 Open-market buy 10% owner bought 400,000 shares at $15.00 ($6,000,000)
- 4 Open-market buy 10% owner bought 266,667 shares at $15.00 ($4,000,005)
- 4 Open-market buy 10% owner bought 333,333 shares at $15.00 ($4,999,995)
- 4 Open-market buy 10% owner bought 333,333 shares at $15.00 ($4,999,995)
- 4 Open-market buy Director bought 266,667 shares at $15.00 ($4,000,005)
- 4 Option exercise Director acquired 263,970 shares (option exercise)
- 4 Conversion 10% owner acquired 1,600,559 shares (conversion)
- 4 Conversion Director acquired 2,506,650 shares (conversion)
- 4 Open-market buy Director bought 6,500 shares at $15.00 ($97,500)
- 4 Open-market buy Director bought 5,000 shares at $15.00 ($75,000)
- 4 Open-market buy VP of Business Dev't bought 500 shares at $15.00 ($7,500)
Page 8 of 9 · 180 filings